[1]Patent:US2010/29650,2010,A1,.Locationinpatent:Page/Pagecolumn50
[1]Patent:US2010/29650,2010,A1,.Locationinpatent:Page/Pagecolumn82
[1]OrganicProcessResearchandDevelopment,2016,vol.20,#8,p.1469-1475
[1]OrganicProcessResearchandDevelopment,2016,vol.20,#8,p.1469-1475
[1]Patent:US2010/29650,2010,A1.Locationinpatent:Page/Pagecolumn82
[1]Patent:US2010/29650,2010,A1.Locationinpatent:Page/Pagecolumn50
[1]Patent:US2010/29650,2010,A1.Locationinpatent:Page/Pagecolumn82
[1]OrganicProcessResearchandDevelopment,2016,vol.20,p.1469-1475
Title: X. Zhu, et al. GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment.
Title: Koji Matsumoto, et al. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats. J Pharmacol Exp Ther. 2018 Dec;367(3):509-517.